Pharmaceutical Grade 99% CAS 150399-23-8 Pemetrexed Disodium
Product Description
Product Name:
|
Pemetrexed disodium
|
Synonyms:
|
n-[4-[2-(2-amino-4,7-dihydro-4-oxo-1h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid disodium salt;PEMETREXED DISODIUM;PEMETREXED DISODIUM(ALIMTA);PEMETREXED SODIUM;PEMETREXED;PEMETREXED DISODIUM 99%;PEMETREXED DISODIUM 2.5H2O;PEMETREXED DISODIUM FOR INJECTION
|
CAS:
|
150399-23-8
|
MF:
|
C20H22N5NaO6
|
MW:
|
451.41
|
EINECS:
|
604-733-2
|
Product Categories:
|
LY-231514;Molecular Targeted Antineoplastic;All Inhibitors;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;Chiral Reagents
|
Product picture
Product Parameters
Pemetrexed disodium Chemical Properties
|
storage temp.
|
Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
|
CAS DataBase Reference
|
150399-23-8(CAS DataBase Reference)
|
Pemetrexed disodium (marketed as ALIMTA®, "pemetrexed") is a novel, multi-targeted antifolate. It suppresses tumor growth by impeding both DNA synthesis and folate metabolism. Pemetrexed disodium has demonstrated promising clinical activity in a wide variety of solid tumors, including non-small cell lung, breast, mesothelioma, colorectal, pancreatic, gastric, bladder, cervix, and head and neck.
Pemetrexed disodium is approved to be used alone or with other drugs to treat malignant pleural mesothelioma in patients who cannot be treated with surgery and non-small cell lung cancer (certain types) in patients whose disease is locally advanced or has metastasized (spread to other parts of the body). Pemetrexed disodium is also being studied in the treatment of other types of cancer.
Company Profile
FAQ